Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diagnostic tools for amyloidosis.

Eric Hachulla1, Gilles Grateau

  • 1Internal medicine department, Centre hospitalier régional et universitaire, Hôpital Claude Huriez, 59037, Lille cedex, France. ehachulla@chru-lille.fr

Joint Bone Spine
|January 23, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD).

Rheumatology (Oxford, England)·2025
Same author

Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitis.

Annals of the rheumatic diseases·2025
Same author

Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database.

Annals of the rheumatic diseases·2025
Same author

A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis.

Rheumatology (Oxford, England)·2025
Same author

Impact of Sjögren's disease on quality of sexual life using the Qualisex score.

RMD open·2025
Same author

Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data.

Arthritis & rheumatology (Hoboken, N.J.)·2024
Same journal

Greater trochanteric bursal distension with intra-bursal rice bodies: an unusual MRI presentation.

Joint bone spine·2026
Same journal

Evaluating the Impact of a Rheumatologist-led Comorbidity Review in Patients with Inflammatory Arthritis.

Joint bone spine·2026
Same journal

What cumulative glucocorticoid dose should trigger sparing strategies in polymyalgia rheumatica?

Joint bone spine·2026
Same journal

Club Rhumatismes et Inflammation guidelines for anti-interleukin-1 therapy: 2026 update.

Joint bone spine·2026
Same journal

Multimodal imaging evaluation of the entheses in spondyloarthritis.

Joint bone spine·2026
Same journal

Club Rhumatismes et Inflammation guidelines for anti-interleukin-1 therapy: 2026 update. What's new?

Joint bone spine·2026
See all related articles

Diagnosing amyloidosis relies on biopsy confirmation. Serum amyloid P (SAP) scintigraphy aids in diagnosis and prognosis, especially when biopsies are inconclusive for this systemic disease.

Area of Science:

  • Medical Diagnostics
  • Pathology
  • Nuclear Medicine

Background:

  • Amyloidosis diagnosis is confirmed by detecting amyloid deposits in biopsy specimens.
  • Nonsurgical biopsies (rectal mucosa, abdominal fat pad, labial salivary glands) achieve 80-85% diagnostic accuracy.
  • Histological typing via immunolabeling is not standard practice.

Purpose of the Study:

  • To outline the diagnostic pathway for amyloidosis.
  • To highlight the role of advanced imaging in confirming and staging amyloidosis.
  • To discuss genetic and protein variant identification in hereditary amyloidosis.

Main Methods:

  • Biopsy of rectal mucosa, abdominal fat pad, or labial salivary glands.
  • Genetic and amyloid protein studies for hereditary cases.

Related Experiment Videos

  • Serum amyloid P (SAP) component scintigraphy for imaging amyloid deposits.

    • Main Results:

    • Biopsies confirm diagnosis in 80-85% of cases.
    • SAP scintigraphy maps amyloid distribution, typically in the liver and spleen.
    • SAP scintigraphy supports diagnosis in histologically negative cases and predicts survival.

    Conclusions:

    • Biopsy remains the gold standard for amyloidosis diagnosis.
    • SAP scintigraphy offers a valuable, non-invasive tool for diagnosis, staging, and prognosis.
    • Comprehensive evaluation includes functional tests and imaging for systemic involvement.